OCT 7·SEC EDGARLow
Kim Hyong sold $270K of ALHC
Kim Hyong (Chief Medical Officer) sold 32,479 shares of Alignment Healthcare, Inc. (ALHC) at $8.30 ($0.27M total) on 2026-10-06.
StockNASDAQ · US · USDHealthcare · Healthcare Plans
$ALHC
Alignment Healthcare, Inc.
AlphAI earnings readSecond Quarter 2026 · JUL 30Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key MetricsVerdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $ALHCvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 2
- Neutral
- 0
- Bearish
- 0
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $9.5M 6 txs
KAO JOHN E3× · $7.5M
10b5-1 share of filings50%
Top stories · $ALHCMore →
OCT 7·financialcontent.com
Why Alignment Healthcare (ALHC) Stock Is Up Today
Alignment Healthcare (ALHC) shares rose 1.9% after announcing plans to expand its Alignment Health Plan to three more California counties and add two health systems to its network for 2027. The expansion covers over 6.3 million Medicare beneficiaries. Shares later cooled to $8.38, up 0.1% from the previous close. The company's stock is down 58.6% year-to-date and 65.9% below its 52-week high.
OCT 7·tradingview.com
Alignment Healthcare (ALHC) Expands to 3 New CA Counties, Adds Hoag and Astrana
Alignment Healthcare (ALHC) announced its Medicare Advantage plan will expand to three new California counties in 2027, adding Hoag and Astrana Health to its provider network, totaling 25 counties served.
ALHC sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning ALHC (Alignment Healthcare, Inc.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent ALHC coverage spans financial news, market movers and insider activity.
In the last 30 days, ALHC insiders filed 6 SEC Form 4 transactions — no purchases and 6 sales ($9.5M). The most active reporter was KAO JOHN E, Chief Executive Officer, with 3 filings. 50% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving ALHC
The insider sale may create modest downward pressure on ALHC stock.
The expansion adds coverage for over 6.3 million Medicare beneficiaries, potentially boosting future revenue and market share.
The expansion adds new geographic coverage and provider relationships, potentially boosting membership and revenue.
CVS Health (NYSE:CVS) reported Q2 revenues of $106.1B, up 7.3% YoY, beating estimates. Progyny (NASDAQ:PGNY) saw revenues of $350.5M, up 5.3% YoY, but missed EBITDA guidance. Clover Health (NASDAQ:CLOV) reported $743.2M in revenues, up 55.6% YoY, exceeding expectations. Molina Healthcare (NYSE:MOH) reported a 4.8% YoY revenue decline, missing estimates. Stock prices reflected mixed reactions to the earnings reports.
The cost‑pressure commentary triggered a sharp sell‑off, pushing the stock to a 52‑week low.
AlphAI scores every news story that mentions ALHC with an AI model for sentiment and relevance, and aggregates insider trades from Alignment Healthcare, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $ALHC
Score
Kim Hyong sold $270K of ALHC
Kim Hyong (Chief Medical Officer) sold 32,479 shares of Alignment Healthcare, Inc. (ALHC) at $8.30 ($0.27M total) on 2026-10-06.
1 min read
Why Alignment Healthcare (ALHC) Stock Is Up Today
Alignment Healthcare (ALHC) shares rose 1.9% after announcing plans to expand its Alignment Health Plan to three more California counties and add two health systems to its network for 2027. The expansion covers over 6.3 million Medicare beneficiaries. Shares later cooled to $8.38, up 0.1% from the previous close. The company's stock is down 58.6% year-to-date and 65.9% below its 52-week high.
2 min read
Alignment Healthcare (ALHC) Expands to 3 New CA Counties, Adds Hoag and Astrana
Alignment Healthcare (ALHC) announced its Medicare Advantage plan will expand to three new California counties in 2027, adding Hoag and Astrana Health to its provider network, totaling 25 counties served.
1 min read
Q2 Earnings Highlights: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Health Insurance Providers Stocks
CVS Health (NYSE:CVS) reported Q2 revenues of $106.1B, up 7.3% YoY, beating estimates. Progyny (NASDAQ:PGNY) saw revenues of $350.5M, up 5.3% YoY, but missed EBITDA guidance. Clover Health (NASDAQ:CLOV) reported $743.2M in revenues, up 55.6% YoY, exceeding expectations. Molina Healthcare (NYSE:MOH) reported a 4.8% YoY revenue decline, missing estimates. Stock prices reflected mixed reactions to the earnings reports.
2 min read
Alignment Shares Tumble on Rising Medical Costs
Alignment Healthcare (ALHC) shares fell 16% after executives cited rising medical costs and claims system issues. CEO John Kao noted the company is addressing these challenges. Despite a 47% drop in the past year, the company maintained its revenue guidance. TD Cowen reiterated a Buy rating with a $21 price target. Alignment is expanding its network with Hoag Memorial Hospital.
2 min readKONOWIECKI JOSEPH S sold $202K of ALHC
KONOWIECKI JOSEPH S (EVP, Corporate Affairs) sold 23,511 shares of Alignment Healthcare, Inc. (ALHC) at $8.61 ($0.20M total) on 2026-09-17.
1 min read
ALHC Stock Plunges As Legal Probes And Cost Headwinds Mount
Alignment Healthcare Inc. (ALHC) stock fell 4.02% amid concerns over Medicare Advantage margins, legal probes, and rising costs. The company reported Q2 2026 revenue of $1.34B and net income of $36.56M, but negative cash flow and legal investigations raise concerns. Analysts cite governance risks and expect further price declines, with fair value estimated at $7–$8.
2 min readAlignment Healthcare (NASDAQ: ALHC) director plans tax-cover sale of 26,000 shares
Alignment Healthcare (ALHC) director and EVP Joseph Konowiecki filed a Rule 144 notice to sell 26,000 shares, valued at $226,460, to cover tax obligations on vested equity awards. The sale is scheduled for September 17, 2026, and is not discretionary. Konowiecki also reported prior sales of 75,000 shares under a 10b5-1 plan.
1 min read
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
Several healthcare stocks fell after bipartisan lawmakers introduced the Protecting Approved Care Act, which aims to reform Medicare Advantage plans. The bill could increase medical loss ratios and administrative burdens for insurers. Astrana Health (ASTH) fell 2.7%, Clover Health (CLOV) 4.8%, Alignment Healthcare (ALHC) 12.6%, and Novavax (NVAX) 3.6%.
2 min readALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
Alignment Healthcare (ALHC) shares dropped 22% after executives declined to discuss next year's quality bonus and noted higher-than-expected hospital bills. CEO John Kao cited CMS sensitivity about commenting on Plan Preview 2. Clover Health (CLOV) also fell 9%. ALHC's CFO mentioned institutional cost headwinds but expects them to ease by 2027. Guidance remained unchanged.
2 min read